1. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus
- Author
-
Kaur, S., Mirza, A. H., Brorsson, C. A., Fløyel, T., Størling, J., Mortensen, H. B., Pociot, F., Aanstoot, H.-J., De Beaufort, Carine, Cameron, F., Castano, L., Dorchy, H., Fisher, L., Kaprio, E., Lange, K., Neu, A., Njolstad, P. R., Phillip, M., Urukami, T., Barrett, T., Chiarelli, F., Danne, T., Hoey, H., Kocova, M., Mortensen, B., Schoenle, J., Swift, G. F., Vanelli, M., Åman, J., and Robert, J.J.
- Subjects
Beta cell ,endocrine system ,Type 1 diabetes ,endocrine system diseases ,B lymphocyte ,Multidisciplinaire, généralités & autres [D99] [Sciences de la santé humaine] ,Apoptosis ,CTCF ,LncRNAs ,ERBB3 ,ERBB3 gene ,Article ,Multidisciplinary, general & others [D99] [Human health sciences] - Abstract
The study aimed to explore the role of ERBB3 in type 1 diabetes (T1D). We examined whether genetic variation of ERBB3 (rs2292239) affects residual β-cell function in T1D cases. Furthermore, we examined the expression of ERBB3 in human islets, the effect of ERBB3 knockdown on apoptosis in insulin-producing INS-1E cells and the genetic and regulatory architecture of the ERBB3 locus to provide insights to how rs2292239 may confer disease susceptibility. rs2292239 strongly correlated with residual β-cell function and metabolic control in children with T1D. ERBB3 locus associated lncRNA (NONHSAG011351) was found to be expressed in human islets. ERBB3 was expressed and down-regulated by pro-inflammatory cytokines in human islets and INS-1E cells; knockdown of ERBB3 in INS-1E cells decreased basal and cytokine-induced apoptosis. Our data suggests an important functional role of ERBB3 and its potential regulators in the β-cells and may constitute novel targets to prevent β-cell destruction in T1D. © 2015 Elsevier Ireland Ltd.
- Published
- 2016